American Journal of Lifestyle Medicine

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rippe, J. M.
Right arrow Articles by Zukley, L.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Lifestyle Medicine, Vol. 1, No. 1, 10-19 (2007)
DOI: 10.1177/1559827606292859

Reviews

The Rationale for Intervention to Reduce the Risk of Coronary Heart Disease

James M. Rippe, MD

Rippe Lifestyle Institute, Shrewsbury, Massachusetts, Florida Hospital Institute for Lifestyle Medicine, Celebration, Florida, Tufts University School of Medicine, Boston, Massachusetts, University of Central Florida, Orlando, bgrady{at}rippelifestyle.com

Theodore J. Angelopoulos, PhD, MPH

Department of Health Professions, Center for Lifestyle Medicine, University of Central Florida, Orlando, Florida

Linda Zukley, MA, RN

Rippe Lifestyle Institute and Rippe Health Assessment, Florida Hospital Celebration Health, Celebration, Florida

Cardiovascular diseases remain extremely common and the United States and are the single most common cause for death in both men and women. Many risk factors including cigarette smoking, elevated cholesterol, high blood pressure, obesity and in inactive lifestyle carry a significant lifestyle component. This fact is recognized in the National Guidelines for the Treatment of many risk factors for cardiovascular disease. Moreover, lifestyle intervention, in combination with proper medical and/or surgical therapy can play a significant role in the management of existing cardiovascular disease. In this review, we provide background and rationale for interventions to reduce the risk of coronary heart disease with a particular emphasis on intervening to improve lifestyle related issues. To achieve the best outcomes clinicians must be skilled not only in pharmacologic and surgical therapies but also in counseling patients on various lifestyle interventions to lower the risk of cardiovascular disease.

Key Words: Coronary heart disease (CHD) • hypertension • dyslipidemia • physical activity • obesity • diabetes • risk factors

References

  • American Heart Association. Heart Disease and Stroke Statistics—2006: An Update. Dallas, Tex: American Heart Association; 2006.
  • Howson CP, Reddy SK, Rayan TJ, Bale JR. Control of Cardiovascular Diseases in Developing Countries. Washington, DC: National Academy Press; 1998.
  • Rippe JM, O'Brien D: The rationale for intervention to reduce the risk of coronary artery disease. In: Rippe JM, ed. Lifestyle Medicine. London: Blackwell Science; 1999.
  • National Institutes of Health, National Heart, Lung and Blood Institute. Fact Book Fiscal Year 2003. Bethesda, Md: National Institutes of Health; 2004.
  • American Heart Association. Heart Disease and Stroke Statistics—2004 Update. Dallas, Tex: American Heart Association; 2003.
  • Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. JAMA. 1993;269: 3002-3002.[Abstract]
  • Eckel R. Obesity and heart disease: a statement for the healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1997;96: 3248-3250.
  • Surgeon General's Report on Physical Activity and Health. Washington, DC: US Department of Health and Human Services, Centers for Disease Control; 1999.
  • US Department of Health and Human Services. Women and Smoking: A Report of the Surgeon General. Rockville, Md: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001.
  • Cigarette smoking among adults—United States, 2000. MMWR Morb Mortal Wkly Rep. 2002;51: 642-642.[Medline] [Order article via Infotrieve]
  • Eyre H, Kahn R, Robertson R. ACS/ADA/AHA scientific statement: preventing cancer, cardiovascular disease and diabetes. Circulation. 2004;109: 3244-3255.
  • Wilson PWF, D'Agostino R, Levy D, Belanger A, Silbershatz H, Kannel W. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97: 1837-1847.[Medline] [Order article via Infotrieve]
  • Kannel WB. Cigarette smoking and coronary heart disease. Ann Intern Med. 1964;60: 1103-1106.
  • Wilson PW, Garrison RJ, Castell WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Framingham Study. N Engl J Med. 1985;313: 1038-1043.[Abstract]
  • Kannel WB, McGee DL, Castelli WP. Latest perspectives on cigarette smoking and cardiovascular disease: the Framingham Study. J Card Rehabil. 1984;4: 267-277.
  • Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J. 1987;113: 1006-1010.[CrossRef][Medline] [Order article via Infotrieve]
  • Shea S, Cook EF, Kannel WB, Goldman L. Treatment of hypertension and its effect on cardiovascular risk factors: data from the Framingham Heart Study. Circulation. 1985;71: 22-30.
  • Kannel WB, Danneberg AL, Abbott RD. Unrecognized myocardial infarction and hypertension: the Framingham Study. Am Heart J. 1985;109: 581-585.[CrossRef][Medline] [Order article via Infotrieve]
  • Harris T, Cook EF, Kannel W, Schatzkin A, Goldman L. Blood pressure experience and risk of cardiovascular disease in the elderly. Hypertension. 1985;7: 118-124.[Abstract/Free Full Text]
  • Castelli WP, Anderson K. A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med. 1986;80: 23-32.[Medline] [Order article via Infotrieve]
  • Kanell WB, Castell WP, Gordon T, McNamara PM. Serum cholesterol, lipo-proteins, and the risk of coronary heart disease: the Framingham Study. Ann Intern Med. 1971;74: 1-12.[Medline] [Order article via Infotrieve]
  • Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol. 1980;46: 649-654.[CrossRef][Medline] [Order article via Infotrieve]
  • Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation. 1983;67: 730-734.
  • McNamara JR, Cohn JS, Wilson PW, Schaefer EJ. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem. 1990;36: 36-42.[Abstract/Free Full Text]
  • Gordon DL, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79: 8-15.
  • Garcia MJ, McNamara P, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population 16-year follow-up study. Diabetes. 1974;23: 105-111.[Medline] [Order article via Infotrieve]
  • Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation. 1979;59: 8-13.
  • Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study. JAMA. 1988;260: 3456-3460.[Abstract]
  • Kannel WB, D’Agostino RB, Wilson PW, Belanger AJ, Gagnon DR. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J. 1990;120: 672-676.[CrossRef][Medline] [Order article via Infotrieve]
  • Fletcher G, Blair S, Blumenthal J, et al. AHA medical/scientific statement. Statement of exercise. Benefits and recommendations for physical activity programs for all Americans. Circulation. 1992;86: 340-344.
  • Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professional. Circulation. 1991;83: 356-356.
  • Kannel WB. Contributions of the Framingham Study to the conquest of coronary artery disease. Am J Cardiol. 1988;62: 1109-1112.[CrossRef][Medline] [Order article via Infotrieve]
  • Wilson P. Clustering of risk factors, obesity, and syndrome X. Nutr Clin Care. 1998;1(Suppl): 44-50.
  • Farmer JA, Gotto AM. Dyslipidemia and Other Risk Factors for Coronary Artery Disease in Braunwald: Heart Disease: A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia: W. B. Saunders; 1997.
  • Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary heart disease: guidance from Framingham. A statement for healthcare professionals from the AHA task force on risk reduction. Circulation. 1998;97: 1876-1887.
  • Stamler J. Epidemiology, established major risk factors and the primary prevention of coronary heart disease. In: Chatterjee K, Cheitlin MP, Karlines J, et al, eds. Cardiology: An Illustrated Text Reference. Vol. 2. Philadelphia: J. B. Lippincott; 1991:1-1.
  • Klag MJ, Ford DE, Mead LA, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993;308: 363-366.
  • Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A. Systematic underestimation of association between serum cholesterol concentration and ischemic heart disease in observational studies: data from the BUPA study. Br Med J. 1994;308: 363-366.[Abstract/Free Full Text]
  • Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease? Br Med J. 1994;308: 367-373.[Abstract/Free Full Text]
  • Garrison RJ, Castelli WP. Weight and thirty-year mortality of men in the Framingham Study. Ann Int Med. 1985;103: 1006-1009.[CrossRef][Medline] [Order article via Infotrieve]
  • Stamler J, Wentworth D, Naton JD. For the MRFIT Research Group: is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Finding in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256;2823-2823.[Abstract]
  • Rimm EB, Stampler MJ, Giovannucci B, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 1995;141: 1117-1127.[Abstract/Free Full Text]
  • Manson JE, Willett WC, Stampler JM, et al. Body weight and mortality among women. N Engl J Med. 1995;141: 1117-1127.
  • Annual smoking attributable mortality, years of potential life lost, and economic costs—United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2000;51: 300-300.
  • Smoking-Related Deaths and Financial Costs: Estimates for 1990. Rev. ed. Washington, DC: Office of Technology Assessment; 1993.
  • Kannel WB, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens. 1990; 8: S3-S3.
  • Negri E, Franzosi MG, LaVecchia C, et al. Tar yield of cigarettes and risk of acute myocardial infarction. BMJ. 1993;306: 1567-1567.[Medline] [Order article via Infotrieve]
  • Bolinder G, Alfredsson L, Englund A, deFaire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994;84: 399-399.[Abstract/Free Full Text]
  • Sigurdsson G Jr, Gudnason V, Sigurdsson G, Humphries SE. Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I. Arterioscler Thromb. 1992;12: 1017-1017.[Abstract/Free Full Text]
  • Tsevat J, Weinstein MC, Williams LW, et al. Expected gains in life expectancy from various coronary heart disease risk factors modifications. Circulation. 1991;83: 1194-1194.
  • Dobvson AJ, Alexander HM, Heller RF, Lloyd DM. How soon after quitting smoking does risk of heart attack decline? J Clin Epidemiol. 1991;44: 1247-1247.[CrossRef][Medline] [Order article via Infotrieve]
  • Physician and other health-care professional counseling of smokers to quit-United States, 1991. MMWR Morb Mortal Wkly Rep. 1993;42: 854-854.[Medline] [Order article via Infotrieve]
  • Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results I. Reduction in incidence of coronary heart disease. JAMA. 1984;251: 351-351.[Abstract]
  • Huttunen JK, Manninen V, Manttair M, et al. The Helsinki Heart Study: central findings and clinical implications. Ann Med. 1991;23: 155-155.[Medline] [Order article via Infotrieve]
  • Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease: report from the Oslo Study Group of a randomized trial in healthy men. Lancet. 1991;2: 1303-1303.[CrossRef]
  • Committee of Principal Investigators. A cooperative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J. 1978;40: 1069-1069.[Free Full Text]
  • Shepherd J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with provastatin in men with hypercholesterolemia. N Engl J Med. 1995;333: 1301-1301.[Abstract/Free Full Text]
  • Brensike JF, Levy RI, Kelsy SF, et al. Effects of therapy with cholestryamine on progression of coronary ateriosclerosis: results of NHLBI Type II Coronary Intervention Study. Circulation. 1984;69: 313-313.
  • Brown G, Albers J, Fisher L, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apoliporotein B. New Engl J Med. 1990;323: 1289-1289.[Abstract]
  • Watts GF, Lewis B, Brunt JNH, et al. Effects on coronary artery disease of lipid-lowering diet or diet plus cholestyramine in the St. Thomas Atherosclerosis Regress Study (STARS). Lancet. 1992;339: 563-563.[CrossRef][Medline] [Order article via Infotrieve]
  • Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholeterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med. 1990;323: 946-946.[Abstract]
  • Wiviott SD, deLemos JA, Cannon CP, et al. A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. Circulation. 2006;113: 1406-1414.
  • Gordon T, Castelli WP, Hjortland MC, et al. High-density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62: 707-707.[CrossRef][Medline] [Order article via Infotrieve]
  • Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991;11: 2-2.[Abstract/Free Full Text]
  • Chobanian AV, Bakris G, Black H, et al, and the National Health High Blood Pressure Education Program Coordinate Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289: 2560-2571.[Abstract/Free Full Text]
  • Kannel WB. Fifty years of Framingham Study contributions to understanding hyper-tension. J Hum Hypertens. 2000;14: 83-90.[CrossRef][Medline] [Order article via Infotrieve]
  • Staessen JA, Gasowski J, Wang JG, et al. Risks of treated and untreated and treated metabolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355: 865-872.[CrossRef][Medline] [Order article via Infotrieve]
  • O'Donnell CJ, Ridker PM, Glynn RJ, et al. Hypertension and borderline isolate systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation. 1997;95: 1132-1132.
  • Working Group on Management of Patients With Hypertension and High Blood Cholesterol. National education programs working group report on the management of hypertension and high blood cholesterol. Ann Intern Med. 1991;114: 224-237.[Medline] [Order article via Infotrieve]
  • Howard BV, Rodriguez BL, Bennett PH, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease Writing Group I: Epidemiology. Circulation. 2002;105: e132-e132.
  • Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care. 1998;21: 1138-1138.[Abstract]
  • National Center for Statistics. Healthy People 2010. Hyattsville, Md: National Center for Statistics; 2005.
  • Powell K, Thompson P, Caspersen C, Kendrick J. Physical activity and the incidence of coronary heart disease. Ann Rev Public Health. 1987;8: 253-287.[CrossRef][Medline] [Order article via Infotrieve]
  • Goldfine H, Ward A, Taylor P, Carlucci D, Rippe JM. Exercising to health: what's really in it for your patients? Part I: The health benefits of exercise. Phys Sports Med. 1991;19: 81-81.
  • Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults: 1999-2000. JAMA. 2002;288: 1723-1727.[Abstract/Free Full Text]
  • Physical status: the use and interpretation of anthropometry: report of a WHO expert committee. World Health Organization Tech Rep Ser. 1995;854: 1-452.
  • Despres JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition. 1993;4: 452-459.
  • Despres JP. Dyslipidaemia and obesity. Bailliere Clinic Endo Metab. 1994;8: 629-660.
  • Willett W, Manson J, Stampfer M, et al. Weight, weight change, and coronary heart disease in women. JAMA. 1995;273: 461-465.[Abstract]
  • Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17: 961-969.[Abstract]
  • American Heart Association. Heart and Stroke Facts. 1995 Statistical Supplement. Dallas, Tex: American Heart Association; 1994.
  • Colditz GA, Rimm EB, Giovannucci E, et al. A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol. 1991;67: 993-993.[CrossRef][Medline] [Order article via Infotrieve]
  • Mosca L, Appel L, Benjamin E, et al. Evidenced-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109: 672-693.
  • Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year old follow-up of the Framingham population. Am Heart J. 1994;15: 1571-1571.
  • Ford ES, Giles WH, Dietz W. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287: 356-356.[Abstract/Free Full Text]
  • Libby P, Ridker PM, Maser A. Inflammation and atherosclerosis. Circulation. 2002;105: 1125-1125.
  • Buffon A, Biasucci LM, Liuzzo G, et al. Widespread coronary inflammation in unstable angina. N Engl J Med. 2002;347: 5-5.[Abstract/Free Full Text]
  • Pradhan AD, Manson JE, Rossouw JE, et al. Inflammatory biomarkers, hormone replacement therapy and incident coronary heart disease: prospective analysis from the Women's Health Initiative Observational Study. JAMA. 2002;288: 980-980.[Abstract/Free Full Text]
  • Albert CM, Ma J, Rifai N, et al. Prospective study of C-reactive protein, homocysteine and plasma lipid levels as predictors of sudden cardiac death. Circulation. 2002;105: 2595-2595.
  • Ridker PM, Cushman M, Stampher MJ, et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336: 973-973.[Abstract/Free Full Text]
  • Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342: 836-836.[Abstract/Free Full Text]
  • Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentration of the intercellular adhesion molecule 1 and risks of future myocardial infarction in inherently healthy men. Lancet. 1998;351: 88-88.[CrossRef][Medline] [Order article via Infotrieve]
  • Ridker P, Libby P. Risk factors for atherothrombotic disease. In: Zipes D, Libby P, Bonow R, Braunwald E., eds. Braunwald's Heart Disease (7th edition). Philadelphia: Elsevier Saunders; 2005.
  • Welch GN, Loscalso J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338: 1042-1050.[Free Full Text]
  • Spence JD, Howard VJ, Chambless LE, et al. Vitamin intervention for stroke prevention (VISP) trial: rationale and design. Neuroepidemiology. 2001;20: 16-16.[CrossRef][Medline] [Order article via Infotrieve]
  • Ridker PM, Manson JE, Buring JE, et al. Homocyst(e)ine and risk of cardiovascular disease among postmenopausal women. JAMA. 1998;281: 1817-1817.
  • Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. Homocystine Lowering Trialists' Collaboration. BMJ. 1998;316: 894-894.[Abstract/Free Full Text]
  • MacMahon M, Kirkpatrick C, Cummings CE, et al. A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocystein (SEARCH). Nutr Metab Cardiovasc Dis. 2000;10: 195-195.[Medline] [Order article via Infotrieve]
  • von Eckardstein A, Schulte H, Cullen P, Assmann G. Lipoprotein (a) further increases the risks of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol. 2001;37: 434-434.[Abstract/Free Full Text]
  • Kronenberg F, Kronenberg MF, Kiechl S, et al. Role of lipoprotein (a) and apolipoprotein (a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation. 1999;100: 1154-1154.
  • Luc G, Bard JM, Arveiller D, et al. Lipoprotein (a) as a predictor of coronary heart disease. The PRIME Study. Arthrosclerosis. 2002;163: 377-377.
  • Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein as a predictor of the risk of ischemic heart disease in men. Prospective trial from the Quebec Cardiovascular Study. Circulation. 1977;95: 69-69.
  • Rosenson RS, Otvos JD, Freedman DS. Relations of lipoproteins subclass levels and low density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of arthrosclerosis in the coronary arteries (PLAC I) trial. Am J Card. 2002;90: 89-89.
  • Pohorecky LA. Interaction of alcohol and stress at the cardiovascular level. Alcohol. 1990;7: 537-546.[CrossRef][Medline] [Order article via Infotrieve]
  • Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high density lipoprotein and its subfractions and decreased risk of myocardial infarction. N Engl J Med. 1993;329: 1829-1834.[Abstract/Free Full Text]
  • Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med. 1993;328: 1444-1444.[Abstract/Free Full Text]
  • Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328: 1450-1450.[Abstract/Free Full Text]
  • Alpha-Tocopheral, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotenes on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330: 1029-1029.[Abstract/Free Full Text]
  • Lachar BL. Coronary-prone behavior: type A behavior revisited. Tex Heart Inst J. 1993;20: 143-143.[Medline] [Order article via Infotrieve]
  • Littman AB. Review of psychosomatic aspects of cardiovascular disease. Psychotera Psychosom. 1993;60: 148-148.
  • Keelan PC, Bielak LF, Ashai K, et al. Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation. 2001;104: 412-412.
  • Achenbach S, Ropers D, Pohle K, et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation. 2002;106: 1077-1077.
  • Hodis, HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness predicting clinical coronary events. Ann Intern Med. 1998;128: 262-269.[Abstract/Free Full Text]
  • O'Leary DH, Plak JF, Kronman RA, Manolio TA, Burke GL, Wolfson SK. Carotid artery intima and media thickness as a risk for myocardial infarction and stroke in older adults. The Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340: 14-22.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rippe, J. M.
Right arrow Articles by Zukley, L.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?